METHYLERGONOVINE Drug Patent Profile
✉ Email this page to a colleague
When do Methylergonovine patents expire, and what generic alternatives are available?
Methylergonovine is a drug marketed by Am Regent, Breckenridge, Amneal Pharms, Chartwell Rx, Granules, Rising, Teva Pharms Usa, and Tp Anda Holdings. and is included in eight NDAs.
The generic ingredient in METHYLERGONOVINE is methylergonovine maleate. There is one drug master file entry for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the methylergonovine maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methylergonovine
A generic version of METHYLERGONOVINE was approved as methylergonovine maleate by AM REGENT on November 24th, 2008.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for METHYLERGONOVINE?
- What are the global sales for METHYLERGONOVINE?
- What is Average Wholesale Price for METHYLERGONOVINE?
Summary for METHYLERGONOVINE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 8 |
| Drug Prices: | Drug price information for METHYLERGONOVINE |
| DailyMed Link: | METHYLERGONOVINE at DailyMed |
US Patents and Regulatory Information for METHYLERGONOVINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Am Regent | METHYLERGONOVINE MALEATE | methylergonovine maleate | INJECTABLE;INJECTION | 090193-001 | Nov 24, 2008 | AP | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Teva Pharms Usa | METHYLERGONOVINE MALEATE | methylergonovine maleate | TABLET;ORAL | 211455-001 | Mar 20, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Chartwell Rx | METHYLERGONOVINE MALEATE | methylergonovine maleate | TABLET;ORAL | 091577-001 | May 2, 2011 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
